COVI-VAC (codenamed CDX-005) is a COVID-19 vaccine developed by Codagenix, Inc. In December 2020, COVI-VAC started a Phase I clinical trial, involving...
6 KB (408 words) - 14:28, 24 August 2023
Russian CoviVac; the Kazakh vaccine QazVac; and the Iranian COVIran Barekat. Vaccines in clinical trials include the Valneva COVID‑19 vaccine.[unreliable...
192 KB (22,024 words) - 20:15, 21 May 2024
Gam-COVID-Vac (Russian: Гам-КОВИД-Вак, the name under which it is legally registered and produced) is an adenovirus viral vector vaccine for COVID-19 developed...
154 KB (13,880 words) - 13:52, 20 April 2024
CoviVac (Russian: КовиВак) is an inactivated virus-based COVID-19 vaccine developed by the Chumakov Centre [ru], which is an institute of the Russian...
8 KB (562 words) - 13:12, 26 July 2023
its third COVID-19 vaccine, CoviVac". Reuters. 20 February 2021. "A new vaccine on the scene: Kazakhstan begins rollout of homegrown QazVac". Fortune...
318 KB (19,351 words) - 20:00, 21 April 2024
inactivated vaccines: Chinese Academy of Medical Sciences, CoronaVac, Covaxin, CoviVac, COVIran Barekat, FAKHRAVAC, Minhai-Kangtai, QazVac, Sinopharm BIBP...
98 KB (20,593 words) - 02:58, 8 March 2024
isothermal amplification (RT‑LAMP) from a nasopharyngeal swab. Several COVID-19 vaccines have been approved and distributed in various countries, many of which...
286 KB (32,740 words) - 23:26, 22 May 2024
encephalitis vaccine Some COVID-19 vaccines: CoronaVac, Covaxin, QazVac, Sinopharm BIBP, Sinopharm WIBP, TURKOVAC, CoviVac Bacterial: Injected typhoid vaccine Cholera...
14 KB (1,238 words) - 17:12, 7 November 2023
SARS-CoV-2 Beta variant (redirect from 501.V2 COVID-19)
vaccine. Covaxin has been found to be effective against the beta variant although with a three fold reduction in neutralization. The CoviVac vaccine Information...
72 KB (6,070 words) - 06:39, 3 February 2024